---
title: "Corcept Therapeutics director David L. Mahoney sells 103,606 shares worth $12.26 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296533256.md"
description: "Corcept Therapeutics director David L. Mahoney sold 103,606 shares on August 18 for approximately $12.26 million. The transaction occurred at prices ranging from $117.47 to $119.64 per share. Following this sale, his holdings in a family trust decreased to 1,133,539 shares."
datetime: "2026-08-20T20:30:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296533256.md)
  - [en](https://longbridge.com/en/news/296533256.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296533256.md)
generator: "portal-rs"
---

# Corcept Therapeutics director David L. Mahoney sells 103,606 shares worth $12.26 million

-   Corcept director David L. Mahoney sold 103,606 shares on Aug. 18. \* Sales priced at $117.47 to $119.64, weighted-average by tranche. \* Holdings in a family trust fell to 1,133,539 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-359255), on August 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CORT.US](https://longbridge.com/en/quote/CORT.US.md)

## Related News & Research

- [Corcept Oncology President Roberto Wandenkolk Vieira disposes of USD 6.31 million in common shares](https://longbridge.com/en/news/297973214.md)
- [Corcept names Roberto Vieira as President, Oncology in initial beneficial ownership filing](https://longbridge.com/en/news/297971867.md)
- [AVI: Revenue and profit rose, with strong cash flow and robust dividends despite market headwinds](https://longbridge.com/en/news/298168223.md)
- [Riskified CTO Shauli Avi sells 30,000 shares for $193,065](https://longbridge.com/en/news/298072843.md)
- [AVI declares final dividend of 418 cents/share, special dividend of 300 cents/share](https://longbridge.com/en/news/298167844.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**